Etripamil
CAS No. 1593673-23-4
Etripamil( MSP-2017 | (-)-MSP-2017 )
Catalog No. M23694 CAS No. 1593673-23-4
Etripamil displays atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells. Etripamil is an antagonist of short-acting L-type calcium-channel.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 215 | In Stock |
|
| 10MG | 340 | In Stock |
|
| 25MG | 621 | In Stock |
|
| 50MG | 1008 | In Stock |
|
| 100MG | 1611 | In Stock |
|
| 500MG | 3222 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEtripamil
-
NoteResearch use only, not for human use.
-
Brief DescriptionEtripamil displays atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells. Etripamil is an antagonist of short-acting L-type calcium-channel.
-
DescriptionEtripamil displays atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells. Etripamil is an antagonist of short-acting L-type calcium-channel. It has a rapid onset of action designed for intranasal administration. It is also used to treat Paroxysmal Supraventricular Tachycardia.
-
In Vitro——
-
In Vivo——
-
SynonymsMSP-2017 | (-)-MSP-2017
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorL-type calcium channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1593673-23-4
-
Formula Weight452.59
-
Molecular FormulaC27H36N2O4
-
Purity>98% (HPLC)
-
SolubilityEthanol : 110 mg/mL (243.05 mM; Need ultrasonic)
-
SMILESO=C(OC)C1=CC=CC(CCN(CCC[C@](C2=CC=C(OC)C(OC)=C2)(C#N)C(C)C)C)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
alpha-L-Rhamnose
Addition of the Rhamnose-rich polysaccharide RROP-1 to normal human dermal fibroblasts (NHDFs) and human endothelial cells produced a dose-dependent stimulation of the calcium-signaling pathway inducing fast and transient increases in Ca2 influx and intracellular free Ca2 level.
-
Ziconotide Acetate
Ziconotide is an analgesic agent and has been used to treat neuropathic and non-neuropathic pain. Ziconotide acts by binding to N-type calcium channels situated on the terminal part of primary afferent neurons of the nociceptive pathway therefore reducing synaptic transmission with potent antinociceptive effects.
-
DHBP dibromide
DHBP dibromide is calcium release and a muscle relaxant inhibitor.
Cart
sales@molnova.com